RxDoctor Payments Data

Donald Kolva

Neurology · Lebanon, PANPI 1396847968

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,068 of the $27,539 with a category attached, or 62.0%. 21 manufacturers reported payments, led by Biogen at 42.9% of the total. Reporting peaked in 2019 at $26,211 and has fallen 99.9% since, to $15 in 2022.

$27,539in general payments, 2019–2025

Across 121 payments — averaging $227.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$12K
  • Teva Pharmaceuticals USA, Inc.$7K
  • Acorda Therapeutics, Inc$7K
  • Novartis$202
  • Sanofi$189
  • Genentech USA, Inc.$163
  • plus $585 from 15 others

What the payments were for

  • Consulting fees$5,09418%
  • Speaking & faculty fees$17,06862%
  • Travel & lodging$2,4619%
  • Food & beverage$2,91511%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,539 in reported general payments places this provider in the 85th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Other neurology in Lebanon

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →